Phentermine Over the Counter Alternative 2026 – OTC Appetite Suppressant Search Trend Analysis Positions PhenQ as a Market Leader According to 1200 Doctors 
Debenture Offering and Delisting
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire /...
Medical Care Technologies Inc. Updates Corporate Website to Highlight Accelerated Global Strategy for AI Mobile Applications
MESA, ARIZONA / ACCESS Newswire / December 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today announced that it...
The Benefits of Restorative Programming for Skilled Nursing Facilities
KENNESAW, GA / ACCESS Newswire / December 30, 2025 / When we picture ourselves or our loved ones aging, we...
DEA Marijuana Year in Review 2025: President Trump Fixing DEA?
How Presidential Leadership Exposed a Marijuana Bureaucracy That Failed Patients, Science, and the Constitution.The only question left is whether the...
Cadrenal’s Pipeline Looks Less Like a Microcap and More Like an Emergency Response System
PONTE VEDRA, FL / ACCESS Newswire / December 30, 2025 / Some companies enter a market because they see opportunity....
Philadelphia Allergy Experts at Becker ENT & Allergy Discuss Proven Methods for Seasonal Allergy Relief
Board-certified providers share guidance on identifying allergy triggers and selecting treatments that align with each patient's symptoms and lifestyle. PHILADELPHIA,...
Health Ministries Worldwide Are Quietly Tightening the Rules on Health IT Vendors
Sovereignty-first procurement is becoming the "zero-trust gate" for national health data screening vendors at RFP intake as AI pipelines, cloud...
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced...
1933 Industries Provides Update on 2024 Debenture Conversions
VANCOUVER, BC / ACCESS Newswire / December 30, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) provides...
Zomedica Launches Next-Generation VETGuardian PLUS(TM) Monitor, Expanding Core Monitoring Platform in Growing Veterinary Market
New platform improves workflow efficiency, strengthens clinical confidence, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire...
TerrAscend Increases Retail Footprint in New Jersey with Closing of Union Chill Dispensary Transaction
Expands New Jersey retail footprint to four dispensaries Dispensary generates over $11 million in annualized revenue and is expected to...
Easy Environmental Solutions Announces Availability Of EasyFEN Liquid Microbial Production System
Company prepares for shipment of first EasyFEN™ system to Africa as part of global deployment strategyMANKATO, Minn., Dec. 30, 2025...
Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108
PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis...
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
With over 80 issued patents and 39 pending patent applications, Autonomix is building a comprehensive, global IP portfolio in nerve-sensing...
SRx Health Solutions Deploys Initial $10 Million into Several Digital Assets Predominantly Bitcoin and Ethereum
NORTH PALM BEACH, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today...
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
LAWRENCEVILLE, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with...
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
TEL AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera...
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and Anxiety SARASOTA, FL, Dec. 30, 2025...
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior,...
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
Rutherford, NJ., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (the “Company”), a medical technology company focused on...